References
Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the pathology working group of the international lymphoma epidemiology consortium (InterLymph). Blood 2007; 110: 695–708.
Nakamura S, Ponzoni M, Campo E. Intravascular large B-cell lymphoma. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th Ed. Swerdlow SH, Campo E, Harris NL, et al. Lyon, France: IARC, 2017: 317–8.
Matsue K, Abe Y, Kitadate A, et al. Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma. Blood 2019; 133: 1257–9.
Lee WJ, Won KH, Won CH, et al. Secondary cutaneous diffuse large B-cell lymphoma has a higher international prognostic index score and worse prognosis than diffuse large B-cell lymphoma, leg type. Acta Derm Venereol 2016; 96: 245–50.
Castillo JJ, Winer ES, Olszewski AJ. Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the surveillance, epidemiology and end results database. Am J Hematol 2014; 89: 310–4.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure. Financial support: none. Conflicts of interest: none
About this article
Cite this article
Enzan, N., Kitadate, A., Yoshioka, M. et al. Cutaneous involvement of diffuse large B-cell lymphoma incidentally diagnosed based on random skin biopsy of normal-appearing skin. Eur J Dermatol 29, 666–667 (2019). https://doi.org/10.1684/ejd.2019.3667
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2019.3667